Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eric Munguakonkwa"'
Autor:
Denis Mukwege, Andreas Kalk, Tim Eckmanns, Andreas Nitsche, Fabian H Leendertz, Tshass B Chasinga, Jean-Paul Buhendwa Cikwanine, Sarah Kribi, Jonathan Tunangoya Yoyu, Natalie Hofmann, Marica Grossegesse, Sara Tomczyk, Ann C Vietor, Aline B Kusinza, Eric Munguakonkwa, Maroyi Raha, Nelson S Kambale, Rodrigue B Ayagirwe, Grit Schubert
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Objectives Healthcare workers (HCWs) are on the frontline of combating COVID-19, hence are at elevated risk of contracting an infection with SARS-CoV-2. The present study aims to measure the impact of SARS-CoV-2 on HCWs in central sub-Saharan Africa.
Externí odkaz:
https://doaj.org/article/f4d69f841c124b7da5d00ab64406ea74
Autor:
Archippe M. Birindwa, Matilda Emgård, Rickard Nordén, Ebba Samuelsson, Shadi Geravandi, Lucia Gonzales-Siles, Balthazar Muhigirwa, Théophile Kashosi, Eric Munguakonkwa, Jeanière T. Manegabe, Didace Cibicabene, Lambert Morisho, Benjamin Mwambanyi, Jacques Mirindi, Nadine Kabeza, Magnus Lindh, Rune Andersson, Susann Skovbjerg
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Pneumococcal conjugate vaccines have been introduced in the infant immunisation programmes in many countries to reduce the rate of fatal pneumococcal infections. In the Democratic Republic of the Congo (DR Congo) a 13-valent vacci
Externí odkaz:
https://doaj.org/article/0435be86df8b4fa088fd5b8d170f094e
Autor:
Benjamin Mwambanyi, Lambert Morisho, Balthazar Muhigirwa, Nadine Kabeza, Susann Skovbjerg, Didace Cibicabene, Rune Andersson, Eric Munguakonkwa, Jeaniere Tumusifu Manegabe, Théophile Kashosi, Lucia Gonzales-Siles, Ebba Samuelsson, Archippe Muhandule Birindwa, Matilda Emgård, Jacques Mirindi, Rickard Nordén, Magnus Lindh, Shadi Geravandi
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Pediatrics
BMC Pediatrics
Background Pneumococcal conjugate vaccines have been introduced in the infant immunisation programmes in many countries to reduce the rate of fatal pneumococcal infections. In the Democratic Republic of the Congo (DR Congo) a 13-valent vaccine (PCV13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::699151320bea2ea713246c42f4097f46
http://link.springer.com/article/10.1186/s12887-018-1332-3
http://link.springer.com/article/10.1186/s12887-018-1332-3